Minimal-change nephrotic syndrome

Also known as: Nephrotic Syndrome, Minimal Change / Minimal change nephrotic syndrome / Minimal Change Nephrotic Syndrome (MCNS) / Nephrotic syndrome with lesion of minimal change glomerulonephritis / Minimal change disease (disorder) / Glomerulonephritis minimal lesion / Minimal change disease / Lipoid nephrosis / Nephrotic syndrome / Minimal change glomerulonephritis / Nephrosis, Lipoid / Nephrotic syndrome with unspecified morphologic changes / Syndrome nephrotic / Nephrotic syndrome (disorder)

Drug	Drug Name	Drug Description
DB00291	Chlorambucil	A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas.
DB00531	Cyclophosphamide	A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma.

Drug	Drug Name	Target	Type
DB00291	Chlorambucil	DNA	target
DB00291	Chlorambucil	Glutathione S-transferase P	enzyme
DB00291	Chlorambucil	Solute carrier organic anion transporter family member 1A2	transporter
DB00291	Chlorambucil	Glutathione S-transferases (Cytosolic)	enzyme
DB00531	Cyclophosphamide	DNA	target
DB00531	Cyclophosphamide	Cytochrome P450 2B6	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C9	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 3A4	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C19	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2A6	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C18	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 2C8	enzyme
DB00531	Cyclophosphamide	Cytochrome P450 3A5	enzyme
DB00531	Cyclophosphamide	Nuclear receptor subfamily 1 group I member 2	target

Drug	Drug Name	Phase	Status	Count
DB00635	Prednisone	2	Recruiting	1
DB00073	Rituximab	2	Recruiting	1
DB00860	Prednisolone	4	Completed	1
DB00635	Prednisone	4	Unknown Status	1
DB00864	Tacrolimus	4	Completed	1